Latest Headlines

• January 6, 2009 - Information Update
  Important Safety Information for the Smoking-Cessation Aid Champix
  Health Canada is reminding Canadians who are taking, or considering taking, the smoking-cessation aid Champix of important safety information for this product. Health Canada is also informing Canadians that it is in the process of further strengthening the labelling for the drug with respect to the risk of serious psychiatric adverse effects.
• December 19, 2008 - Information Update
  Diabetes Drug Actos and Risk of Heart Failure
  Health Canada is informing diabetic patients taking Actos (the brand name for the prescription drug pioglitazone hydrochloride) of recent changes to the prescribing information for this product.
• December 18, 2008 - Advisory
  Decision on the Labelling of Cough and Cold Products for Children
  Health Canada is advising consumers of the outcome of its review of cough and cold medicines for children under the age of 12.
• Media Room

Highlights

• Canadian Adverse Reaction Newsletter - January 2009 edition
• Careers at Health Canada
• Sun Safety
• Melamine in Food Products
• Listeria and Food Safety

Print | Need Larger Text?